Pathways to Improved Outcomes: Diagnosis, Monitoring, and Individualized Treatment of Progressive Fibrosing ILD

Pathways to Improved Outcomes: Diagnosis, Monitoring, and Individualized Treatment of Progressive Fibrosing ILD is organized by Paradigm Medical Communications, LLC.

Release Date: November 26, 2019
Expiration Date: November 26, 2020

Accreditation:
Physician Credit Designation Statement:
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education:
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Learning Objectives:
Upon proper completion of this activity, participants should be better able to:
• Correctly identify patients with a phenotype of PF-ILD 
• Describe appropriate monitoring and subsequent impact on morbidity and mortality of these assessments for patients with PF-ILD
• Assess evidence from recent and ongoing clinical trials for its impact on the management of PF-ILD

Additional details will be posted as soon as information is available.